Impact BioMedical Receivables

Impact BioMedical (IBO) currently reports a receivables of $200K as of March 2026. That compares with $200K in the prior-year period — down 2.5% year over year. Use the charts on this page to explore Impact BioMedical's receivables history and peer comparisons.

Impact BioMedical's receivables decreased from $200K to $200K — a 2.5% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Impact BioMedical reported $200K in receivables as of March 2026. That compares with $200K in the prior-year period — down 2.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $200K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Impact BioMedical, and consider following IBO for alerts when major investors trade the stock.

Impact BioMedical is classified in the Healthcare sector. On receivables, it currently shows $200K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IBO with unrelated industries.